SG11201602289WA - Polypeptide exhibiting fluorescent properties, and utilization of same - Google Patents

Polypeptide exhibiting fluorescent properties, and utilization of same

Info

Publication number
SG11201602289WA
SG11201602289WA SG11201602289WA SG11201602289WA SG11201602289WA SG 11201602289W A SG11201602289W A SG 11201602289WA SG 11201602289W A SG11201602289W A SG 11201602289WA SG 11201602289W A SG11201602289W A SG 11201602289WA SG 11201602289W A SG11201602289W A SG 11201602289WA
Authority
SG
Singapore
Prior art keywords
utilization
same
fluorescent properties
polypeptide exhibiting
exhibiting fluorescent
Prior art date
Application number
SG11201602289WA
Other languages
English (en)
Inventor
Atsushi Miyawaki
Ryoko Ando
Original Assignee
Riken
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Riken filed Critical Riken
Publication of SG11201602289WA publication Critical patent/SG11201602289WA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/60—Fusion polypeptide containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
SG11201602289WA 2013-08-23 2014-08-22 Polypeptide exhibiting fluorescent properties, and utilization of same SG11201602289WA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2013173850 2013-08-23
PCT/JP2014/072039 WO2015025959A1 (ja) 2013-08-23 2014-08-22 蛍光特性を示すポリペプチド、およびその利用

Publications (1)

Publication Number Publication Date
SG11201602289WA true SG11201602289WA (en) 2016-05-30

Family

ID=52483729

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201602289WA SG11201602289WA (en) 2013-08-23 2014-08-22 Polypeptide exhibiting fluorescent properties, and utilization of same

Country Status (5)

Country Link
US (1) US10030055B2 (ja)
EP (1) EP3037534B1 (ja)
JP (1) JP6667897B2 (ja)
SG (1) SG11201602289WA (ja)
WO (1) WO2015025959A1 (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CR20220096A (es) 2019-09-06 2022-05-11 Novartis Ag Proteínas de fusión terapéuticas
CN110672558B (zh) * 2019-09-24 2022-05-10 东南大学 基于oct技术的神经活动观测方法及系统
JP2023057069A (ja) * 2021-10-08 2023-04-20 国立研究開発法人理化学研究所 蛍光ｖｈｈ抗体

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5491084A (en) 1993-09-10 1996-02-13 The Trustees Of Columbia University In The City Of New York Uses of green-fluorescent protein
US5882893A (en) * 1997-12-04 1999-03-16 Millennium Pharmaceuticals, Inc. Nucleic acids encoding muscarinic receptors and uses therefor
AUPP846399A0 (en) 1999-02-02 1999-02-25 University Of Sydney, The Pigment protein from coral tissue
CA2383642C (en) 1999-10-14 2014-03-25 Clontech Laboratories, Inc. Anthozoa derived chromophores/fluorophores and methods for using the same
ATE443135T1 (de) 2003-06-16 2009-10-15 Riken Fluoreszenzprotein und pigmentprotein
US7230080B2 (en) * 2005-02-16 2007-06-12 University Of Florida Research Foundation, Inc. Fluorescent and colored proteins, and polynucleotides that encode these proteins
AU2006325975B2 (en) 2005-12-13 2011-12-08 Kyoto University Nuclear reprogramming factor
JP2010110289A (ja) 2008-11-10 2010-05-20 Univ Of Tokyo ｉＰＳ細胞の樹立法
JP5637354B2 (ja) 2009-03-30 2014-12-10 独立行政法人産業技術総合研究所 精製転写因子の調製法と細胞導入技術
WO2012074117A1 (ja) 2010-12-03 2012-06-07 国立大学法人京都大学 効率的な人工多能性幹細胞の樹立方法
FR2976586B1 (fr) 2011-06-15 2015-01-23 Centre Nat Rech Scient Methode pour generer des proteines fluorescentes cyans ayant une sensibilite reduite au ph

Also Published As

Publication number Publication date
US20160280746A1 (en) 2016-09-29
EP3037534B1 (en) 2021-02-17
EP3037534A1 (en) 2016-06-29
WO2015025959A1 (ja) 2015-02-26
JPWO2015025959A1 (ja) 2017-03-02
JP6667897B2 (ja) 2020-03-18
US10030055B2 (en) 2018-07-24
EP3037534A4 (en) 2017-07-05

Similar Documents

Publication Publication Date Title
IL276106A (en) Garp-binding proteins and their uses
IL261743B (en) and their uses 33–il antibodies against
IL261547B (en) Antibodies against pesidine and their uses
HK1214969A1 (zh) 抗- -β抗體及其使用
IL243974A0 (en) Antibodies against -prlr and uses
ZA201508896B (en) Anti-c10orf54 antibodies and uses thereof
IL240091A0 (en) Quinoline and quinazoline amides, preparations containing them and their uses
SG10201709715RA (en) Anti-b7-h5 antibodies and their uses
SG11201509116VA (en) Anti-tweakr antibodies and uses thereof
HK1218314A1 (zh) 膿毒症生物標誌物及其應用
EP2963115A4 (en) NOVEL POLYPEPTIDE WITH FLUORESCENT PROPERTIES AND USE THEREOF
HUE037843T2 (hu) Új ellenanyag fragmensek, készítmények és ezek használata
SG11201602289WA (en) Polypeptide exhibiting fluorescent properties, and utilization of same
ZA201601880B (en) Hetero-transglycosylase and uses thereof
EP3015549A4 (en) NOVEL POLYPEPTIDE AND USE THEREOF
EP3015548A4 (en) Novel polypeptide, and use thereof
GB201308639D0 (en) Biomarkers and uses of thereof
EP2990481A4 (en) NOVEL RECOMBINANT CELLULASE AND USE THEREOF
EP3006564A4 (en) NEW PEPTIDE AND ITS USE